HCP Targeting

Key facts

Core identifier

National Provider Identifier (NPI) from CMS NPPES

Public prescribing data

CMS Medicare Part D Prescribers, by NPI and drug, released annually

Public procedure data

CMS Medicare Physician and Other Practitioners, by NPI and HCPCS code

Small-count privacy rule

Counts under 11 are suppressed or excluded in public Medicare provider files

Physician opt-out

AMA Physician Data Restriction Program limits rep access to prescribing data

What is HCP targeting?

HCP targeting turns the full universe of licensed clinicians into a ranked list of the professionals a company should reach for a given product. A target list records who each HCP is, why they matter for the brand and which engagement plan applies: field visits, digital outreach, medical science liaison contact or no contact.

Targeting is product specific. A cardiologist who is a top target for a heart failure drug may be irrelevant for a therapy used mostly in primary care, so companies build and refresh lists brand by brand and indication by indication.

In a compliant program, the target universe reflects the approved indication. Selecting clinicians because they treat patients outside the label invites scrutiny for off-label promotion.

How HCP targeting works

Most targeting programs follow the same steps:

• Define the universe: specialties, identified by NUCC taxonomy codes linked to the NPI, that treat the indicated patient population.
• Size potential: estimate each HCP's relevant patient volume from claims, Medicare Part D Prescribers files or procedure data.
• Rank: assign deciles or tiers so the highest-potential clinicians receive the most attention.
• Add context: health system affiliations, local formulary access and whether the practice restricts representative visits.
• Assign channels and frequency, then measure response and refresh the list.

Why HCP targeting matters

Field force time is one of the most expensive promotional resources, so targeting accuracy drives return on sales spend. Launch teams use targeting to reach likely early adopters, and brand teams use it to shift effort as competitors enter or a product nears loss of exclusivity.

Targeting also shapes non-sales work. Medical affairs teams map experts for scientific exchange, clinical operations teams look for high-volume treaters as potential trial sites, and device companies focus on surgeons by procedure volume.

Limitations of public targeting data

Medicare files cover only Medicare patients and lag the current year by about two years, so they understate clinicians who mainly see commercially insured or pediatric patients. NPPES addresses are self-reported and may reflect a billing office rather than where the clinician practices.

Rules on prescriber data have been litigated. In Sorrell v. IMS Health (2011), the Supreme Court struck down a Vermont law that restricted the sale and use of prescriber-identifiable data for marketing, and physicians can instead limit representative access to their data through the AMA program.